Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
KleenGel
AddedFeb 18, 2024
UpdatedJun 18, 2026
KleenGel

KleenGel

Seed

KleenGel: Providing touch-free, cross-contamination-free medical devices for safe exams since 2012.

HQ
Boca Raton, FL, US
Founded
2012
Overview
Compare
Fundraising
Employees

KleenGel's mission is to enhance medical safety by providing touch-free, cross-contamination-free devices for pelvic and rectal exams. Their innovative technology eliminates the need to touch lubricating gel tubes or packets, significantly reducing contamination risks. Founded in 2012, KleenGel is headquartered in Boca Raton, Florida, and focuses on improving hygiene standards in medical practices.

KleenGel has made significant strides in medical safety, with its products being adopted by numerous healthcare providers. The company's impact on reducing infection rates and improving patient care has been widely recognized. Their pioneering approach has set new standards in medical hygiene, contributing to safer clinical environments.

KleenGel - Similar Companies

Gant Medical logo

Gant Medical

gantmed.com

ClearSpec logo

ClearSpec

ClearLine MD logo

ClearLine MD

CleanEndo logo

CleanEndo

Endoclear logo

Endoclear

Novogiene logo

Novogiene

HyGIeaCare logo

HyGIeaCare

OpenClean Technologies logo

OpenClean Technologies

ClearFlow logo

ClearFlow

clearflow.com

SteriDev logo

SteriDev

steridev.com

Touchless Care Concepts logo

Touchless Care Concepts

Radux Devices logo

Radux Devices

raduxdevices.com

Medical Grade Innovations logo

Medical Grade Innovations

Contagiend Solutions logo

Contagiend Solutions

Sterifre Medical logo

Sterifre Medical

sterifre.com

KleenGel - Quick Facts

Who are KleenGel's competitors?

Companies similar to KleenGel include Gant Medical, ClearSpec, ClearLine MD and CleanEndo.

When was KleenGel founded?

KleenGel was founded in 2012.

Where is KleenGel's headquarters located?

KleenGel's headquarters is located in Boca Raton, FL, US.

When was KleenGel's last funding round?

KleenGel's most recent funding round was for $200k (USD) in May 2020.

How much has KleenGel raised to-date?

As of May 18, 2020, KleenGel has raised a total of $300k (USD).

How many employees does KleenGel have?

KleenGel has 30 employees as of Feb 5, 2024.

KleenGel - Classification

Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
Tags
  • Hardware
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified